BackIntelligent Medicine Acquisition Overview
Intelligent Medicine Acquisition Corp - Class A

Intelligent Medicine Acquisition Return on Equity

Intelligent Medicine Acquisition (IQMD) has a ROE of 2157193.89%, above the sector sector average of -5.68%.

Get informed when a big investor buys or sells

+ Follow

ROE

2157193.89%

Return on Equity

2157193.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Intelligent Medicine Acquisition (IQMD) FAQ

As of the most recent data, IQMD shows a ROE of 2157193.89%. That is above the sector sector average of -5.68%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -5.68%. Intelligent Medicine Acquisition is at 2157193.89%, which is higher that average. That is roughly 37957712.1% above the sector mean. Use the comparison chart on this page to see how IQMD stacks up against individual peers as well.

Check the historical chart to see whether IQMD's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Intelligent Medicine Acquisition with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Intelligent Medicine Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 2157193.89%) with ownership activity and broader fundamentals.